« Back to Record
Dixon, B. P., Kavanagh, D. D., Aris, A. D. M., Adams, B., Kang, H. G., Wang, E., Garlo, K., Ogawa, M., Amancha, P., Chakravarty, S., Heyne, N., Kim, S. H., Cataland, S., Yoon, S. S., Miyakawa, Y., Luque, Y., Muff-Luett, M., Tanaka, K., & Greenbaum, L. L. (2024). Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials. Kidney Medicine, 6(8), 100855. doi:10.1016/j.xkme.2024.100855
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/376801



